IDH-wildtype GBM represent a distinct molecular entity defined by the absence of mutations in the IDH1 or IDH2 genes, and are known to be associated with more aggressive biological behavior compared to their IDH-mutant counterparts [15,16]. The gene discussed is IDH2; the disease is glioblastoma.